Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Breaking News: Business Business News Eisai Co Ltd
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Meta Platforms Inc PRO: Playbooks DR Horton Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Biogen Inc Starbucks Corp
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Investment strategy WABTEC CORP DRN Netflix Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags 5 Things to Know Boeing Co Norfolk Southern Corp
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Companies Breaking news Business
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags US: News Earnings Pharmaceuticals
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Breaking News: Business Business News Science
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Eisai Co Ltd Business News Science
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Eli Lilly and Co Investing U/S/ Markets
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Market Outlook Stock Picks Kratos Defense and Security Solutions Inc
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Breaking news Companies Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags NVIDIA Corp Business News Meta Platforms Inc
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Health care industry Healthy Returns Health & Science
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Business Biogen Inc Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags DraftKings Inc Markets PepsiCo Inc/
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Social issues US: News Health & Science
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Health & Science Pharmaceuticals Amgen Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Rivian Automotive Inc Investment strategy MGM Resorts International
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Pharmaceuticals Health & Science US: News
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Intel Corp Chevron Corp Pfizer Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Earnings Stock markets United Parcel Service Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business Health & Science Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Citigroup Inc Politics Markets
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Biogen Inc Business Health care industry
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Pharmaceuticals Health & Science Law and Regulation
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.